These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 21699079

  • 1. Preparation, characterization and dissolution enhancement of mefloquine hydrochloride-betaCD inclusion complex.
    Patil SS, Patil AL.
    Pharmazie; 2011 Jun; 66(6):416-20. PubMed ID: 21699079
    [Abstract] [Full Text] [Related]

  • 2. Solid-state characterization and dissolution properties of bicalutamide-beta-cyclodextrin inclusion complex.
    Patil AL, Pore YV, Kuchekar BS, Late SG.
    Pharmazie; 2008 Apr; 63(4):282-5. PubMed ID: 18468387
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
    Liu L, Zhu S.
    J Pharm Biomed Anal; 2006 Jan 23; 40(1):122-7. PubMed ID: 16095859
    [Abstract] [Full Text] [Related]

  • 7. Analysis of triclosan inclusion complexes with β-cyclodextrin and its water-soluble polymeric derivative.
    Jug M, Kosalec I, Maestrelli F, Mura P.
    J Pharm Biomed Anal; 2011 Apr 05; 54(5):1030-9. PubMed ID: 21215544
    [Abstract] [Full Text] [Related]

  • 8. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW, Kim MS, Kim JS, Park HJ, Lee S, Woo JS, Hwang SJ.
    Eur J Pharm Biopharm; 2007 Jun 05; 66(3):413-21. PubMed ID: 17240129
    [Abstract] [Full Text] [Related]

  • 9. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
    Figueiras A, Carvalho RA, Ribeiro L, Torres-Labandeira JJ, Veiga FJ.
    Eur J Pharm Biopharm; 2007 Sep 05; 67(2):531-9. PubMed ID: 17451924
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Fosinopril-cyclodextrin inclusion complexes: phase solubility and physicochemical analysis.
    Sbârcea L, Udrescu L, Drăgan L, Trandafirescu C, Szabadai Z, Bojiţă M.
    Pharmazie; 2011 Aug 05; 66(8):584-9. PubMed ID: 21901980
    [Abstract] [Full Text] [Related]

  • 13. Preparation and characterization of inclusion complex of norflurazon and beta-cyclodextrin to improve herbicide formulations.
    Villaverde J, Morillo E, Pérez-Martínez JI, Ginés JM, Maqueda C.
    J Agric Food Chem; 2004 Feb 25; 52(4):864-9. PubMed ID: 14969543
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Physicochemical characteristics and bioavailability of a novel intestinal metabolite of ginseng saponin (IH901) complexed with beta-cyclodextrin.
    Lee PS, Han JY, Song TW, Sung JH, Kwon OS, Song S, Chung YB.
    Int J Pharm; 2006 Jun 19; 316(1-2):29-36. PubMed ID: 16574357
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dissolution enhancement of cefdinir with hydroxypropyl-β-cyclodextrin.
    Guo B, Zhong S, Li N, Li X, Yi J, Jin M.
    Drug Dev Ind Pharm; 2013 Nov 19; 39(11):1638-43. PubMed ID: 24087855
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.